Spyre Therapeutics, Inc. Annual Depreciation, Depletion and Amortization in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Spyre Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2014 to 2023.
  • Spyre Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Spyre Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $744K, a 52.5% decline from 2022.
  • Spyre Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.57M, a 0.57% decline from 2021.
  • Spyre Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.58M, a 58.2% increase from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $744K -$823K -52.5% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-11-18
2022 $1.57M -$9K -0.57% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-11-18
2021 $1.58M +$580K +58.2% Jan 1, 2021 Dec 31, 2021 10-K/A 2024-11-18
2020 $996K +$578K +138% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $418K +$125K +42.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $293K +$44K +17.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $249K +$117K +88.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $132K +$43K +48.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $89K +$70K +368% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 $19K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.